Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

503
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
503
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

185
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
185
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

560
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
560
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

125
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
125
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

104
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

121
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why AI can't be trusted to write scientific reviews.

Nature·2026
Same author

Global Variations in Practices after Bariatric and Metabolic Surgery; the PARTNER Study.

Obesity surgery·2025
Same author

Perspectives on Artificial Intelligence in Medical Publishing: A Survey of Medical Journal Editors.

Journal of cardiovascular pharmacology·2025
Same author

International partnership for governing generative artificial intelligence models in medicine.

Nature medicine·2025
Same author

An international Delphi consensus on patient preparation for metabolic and bariatric surgery.

Clinical obesity·2024
Same author

5 years of The Lancet Digital Health.

The Lancet. Digital health·2024
Same journal

Deception in clinical large language models: an under-recognised safety risk.

The Lancet. Digital health·2026
Same journal

Large language models and the mental health crisis.

The Lancet. Digital health·2026
Same journal

Equity in virtual urgent care: lessons from health system-based models.

The Lancet. Digital health·2026
Same journal

Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model.

The Lancet. Digital health·2026
Same journal

Ensuring the clinical impact of medical artificial intelligence.

The Lancet. Digital health·2026
Same journal

Precision medicine's inevitable trajectory toward rare-disease-sized cohorts: implications for machine learning and deep learning.

The Lancet. Digital health·2026
See all related articles

Related Experiment Video

Updated: Nov 9, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.0K

Cardiology and big data: a call for papers

Stuart Spencer1, Rupa Sarkar2

  • 1The Lancet, London EC2Y 5AS, UK.

The Lancet. Digital Health
|April 10, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Semi-automated Optical Heartbeat Analysis of Small Hearts
12:10

Semi-automated Optical Heartbeat Analysis of Small Hearts

Published on: September 16, 2009

12.5K

Related Experiment Videos

Last Updated: Nov 9, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.0K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Semi-automated Optical Heartbeat Analysis of Small Hearts
12:10

Semi-automated Optical Heartbeat Analysis of Small Hearts

Published on: September 16, 2009

12.5K